Papa John’s (PZZA) stock jumped 3.5% today after CEO Rob Lynch expressed confidence during the ICR Conference presentation, affirming the company's ability to attain 2-4% comparable sales growth in 2024, aligning with its long-term targets.
Similarly, Catalent (NYSE:CTLT) stock is up 6.3% after the company presented at JPMorgan’s conference.
“We believe we can continue to gain share because of our offering and capabilities and culture. But also the overall market that we play in, we'll see an exciting expansion as we move forward,” it is said in a presentation.
“So all these elements are really underpinning the growth conviction that we have for the company going forward.”
The company maintained its perspective on GLP-1s as a crucial revenue generator until 2030. Projections indicate revenue to be less than $100 million in FY2024, with an expected increase to over $500 million by FY2026, factoring in current and planned capacity investments.
A substantial portion of the upcoming pre-filled syringe (PFS) capacity will be dedicated to GLP-1s. Catalent assesses the current GLP-1 market at approximately $6 billion in 2023, anticipating growth to around $100 billion by 2030.